Aytu BioPharma amends warrants to address accounting classification.
Share this article
Corporate
Score 25
Neutral
Aytu BioPharma amends warrants to address accounting classification
Apr 02, 2026 23:47 UTC
AYTU
Short term
Related Articles
Score 25
Form 13D/A Stablecoin Development Corp For: 2 April
Apr 03, 01:54
Score 25
Coreweave CFO Agrawal sells $1184 in shares
Apr 03, 01:38
Score 25
Lyon McKinsey of Perpetua Resources sells $256k in shares
Apr 03, 01:37
Score 25
Cherry Jonathan, Perpetua Resources CEO, sells $119555 in shares
Apr 03, 01:37
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.